PureTech Health's Vor wins FDA fast-track approval for cancer drug

10th Sep 2021 07:38

(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
The US Food and Drug Administration granted the designation to VOR33, a hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukaemia.

Top Risers

Share	Price	Change
Clontarf (CLON)	0.05	0%
Uk Oil & Gas (UKOG)	0.0352	0%
Keller (KLR)	1,376.00	0%
Kore Potash (KP2)	0.75	0%
Belluscura (BELL)	12.25	0%

Top Fallers

Share	Price	Change
Braveheart Inv (BRH)	4.25	0%
ValiRx (VAL)	1.90	0%
Oracle Power (ORCP)	0.0195	0%
Cloudified Holdings Limited (CHL)	4.00	0%
Lifesafe Hldg (LIFS)	12.50	0%

Top By Volume

Share	Price	Volume
Clontarf (CLON)	0.05	0
Lloyds (LLOY)	54.50	0
Beacon Energy. (BCE)	0.055	0
Oracle Power (ORCP)	0.0195	0
Tower Resources (TRP)	0.0185	0

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.